Strategies to Increase the Resectability of Liver Metastases from Colorectal Cancer
Authors:
- 1 July 2003
- journal article
- review article
- Published by S. Karger AG in Digestive Surgery
- Vol. 20 (6) , 481-496
Abstract
Liver resection can provide long-term survival and cure for patients with colorectal liver metastases but is feasible in only 15–25% of patients. In the last few years several major developments have contributed to increase this resectability rate. Neo-adjuvant chemotherapy can provide response rates as high as 50%, allowing surgery in about 10–15% of patients initially deemed unresectable. Patients requiring extensive liver resections with an anticipated small residual liver volume can undergo portal vein embolization to reduce the risk of postoperative liver failure by inducing hypertrophy of the remnant liver. Extensive bilobar disease can be treated by two-stage hepatectomy, with an interval to allow liver regeneration. Ablation techniques can be combined with hepatic resection to reduce local recurrence from incomplete surgical resection margins or to destroy contralateral tumor deposits. Finally, for patients with tumors involving the inferior vena cava or the hepatic veins, in which conventional resection is not feasible, in situ hypothermia or bench resection with reimplantation are suitable for very selected patients. Downstaging strategies may increase the resectability rate of colorectal liver metastases by over 20%.Keywords
This publication has 45 references indexed in Scilit:
- Long-term results of treating hepatic colorectal metastases with cryosurgeryBritish Journal of Surgery, 2001
- Portal vein embolization: rationale, technique and future prospectsBritish Journal of Surgery, 2001
- Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver TumorsAnnals of Surgery, 2000
- Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured LiverAnnals of Surgery, 2000
- Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection aloneEuropean Journal of Surgical Oncology, 2000
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerThe Lancet, 1997
- Repeat Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 1997
- Preoperative portal vein embolization for extension of hepatectomy indicationsHepatology, 1996
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996